Abstract

This study retrospectively compares patients who underwent outpatient transvaginal follicle aspiration with either a propofol- or methohexital-based intravenous sedation technique. Data collected from patient charts (n = 212) over a 46-month period were analyzed to determine the effects of each sedation technique on procedure and recovery times, number of retrieved ova, as well as rates of nausea, fertilization, cleavage, pregnancy, and delivery. All patients were included in the study, regardless of age or diagnosis. Procedure time was lower in the propofol group (51 ± 18 minutes) than in the methohexital group (61 ± 20 minutes) (P < 0.01). Patients in the methohexital group (139 ± 51 minutes) spent more time in the recovery room than did those in the propofol group (71 ± 34 minutes) (P < 0.01). The nausea rates were significantly lower in the propofol group compared with the methohexital group (1.9% vs 14.4%, respectively) (P < 0.02). Fertilization rate in the propofol group was 77.7% and was 62.9% in the methohexital group (P < 0.01). The numbers of retrieved ova and the cleavage rates were similar in both groups. The rate of pregnancy in patients sedated with propofol (46.1%) was higher than the methohexital group (26.9%) (P < 0.02). Delivery rate was 38.5% in the propofol group and 20.6% in the methohexital group (P < 0.02). In summary, propofol intravenous sedation for transvaginal follicle aspiration was associated with an improved outcome. Pregnancy and delivery rates were higher while nausea, an unpleasant side effect, was sharply reduced.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call